PortfoliosLab logoPortfoliosLab logo
ARCT vs. CBAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARCT vs. CBAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcturus Therapeutics Holdings Inc. (ARCT) and CBAK Energy Technology, Inc. (CBAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ARCT

1D
-2.70%
1M
-20.88%
6M
-22.89%
YTD
-6.04%
1Y
-53.17%
3Y*
-45.16%
5Y*
-28.72%
10Y*
ALL TIME*
-16.73%

CBAT

1D
0.83%
1M
-17.56%
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$2.42M$3.57M$3.41M
$58.72K$78.51K$75.46K

ARCT vs. CBAT - Yearly Performance Comparison


Correlation

The correlation between ARCT and CBAT is -0.13, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jun 30, 2026

-0.13

Fundamentals

Market Cap

ARCT:

$163.72M

CBAT:

$44.25M

EPS

ARCT:

-$1.80

CBAT:

-$0.10

PS Ratio

ARCT:

3.40

CBAT:

0.23

PB Ratio

ARCT:

0.86

CBAT:

0.00

Total Revenue (TTM)

ARCT:

$46.80M

CBAT:

$195.19M

Gross Profit (TTM)

ARCT:

$40.72M

CBAT:

$18.42M

EBITDA (TTM)

ARCT:

-$84.61M

CBAT:

-$18.44M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARCT vs. CBAT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ARCT
ARCT Risk / Return Rank: 2121
Overall Rank
ARCT Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
ARCT Sortino Ratio Rank: 2323
Sortino Ratio Rank
ARCT Omega Ratio Rank: 2222
Omega Ratio Rank
ARCT Calmar Ratio Rank: 1818
Calmar Ratio Rank
ARCT Martin Ratio Rank: 2626
Martin Ratio Rank

CBAT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ARCT vs. CBAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and CBAK Energy Technology, Inc. (CBAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARCTCBATDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.94

Calmar ratioReturn relative to maximum drawdown

-0.70

Martin ratioReturn relative to average drawdown

-0.89

ARCT vs. CBAT - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ARCT vs. CBAT - Drawdown Comparison

The maximum ARCT drawdown since its inception was -95.53%, which is greater than CBAT's maximum drawdown of -19.77%. Use the drawdown chart below to compare losses from any high point for ARCT and CBAT.


Loading charts...

Drawdown Indicators


ARCTCBATDifference

Max Drawdown

Largest peak-to-trough decline

-95.53%

-19.77%

-75.76%

Max Drawdown (1Y)

Largest decline over 1 year

-76.12%

Max Drawdown (3Y)

Largest decline over 3 years

-87.54%

Max Drawdown (5Y)

Largest decline over 5 years

-90.34%

Current Drawdown

Current decline from peak

-95.34%

-17.56%

-77.78%

Average Drawdown

Average peak-to-trough decline

-73.48%

-13.44%

-60.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

59.69%

Volatility

ARCT vs. CBAT - Volatility Comparison


Loading charts...

Volatility by Period


ARCTCBATDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.40%

Volatility (6M)

Calculated over the trailing 6-month period

39.07%

Volatility (1Y)

Calculated over the trailing 1-year period

90.94%

65.62%

+25.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

91.54%

65.62%

+25.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

101.26%

65.62%

+35.64%

Dividends

ARCT vs. CBAT - Dividend Comparison

Neither ARCT nor CBAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ARCT vs. CBAT - Financials Comparison

This section allows you to compare key financial metrics between Arcturus Therapeutics Holdings Inc. and CBAK Energy Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ARCT and CBAT have a correlation of -0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ARCT and CBAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer